文献速递中药与中成药合理使用中医内科

桃红四物汤抗血栓质量标志物多维整合策略研究

A multidimensional integrated strategy for identifying anti-thrombotic quality markers(Q-Markers) in Taohong Siwu decoction through combined analysis of chemical profiling, bioactivity, and pharmacodynamic efficacy.
PubMed 文献 · J Ethnopharmacol · 2026-05-29

本研究以桃红四物汤(TSD)为对象,采用UPLC-QqQ-MS/MS定量31个成分,结合体外抗凝抗血小板实验与斑马鱼血栓模型,通过灰色关联分析和BP神经网络建立谱效关系,并经分子对接与qRT-PCR验证,最终确定6个抗血栓质量标志物。

要点

  • 桃红四物汤抗血栓质量标志物为地黄苷D、苦杏仁苷、芍药苷、阿魏酸、羟基红花黄色素A和绿原酸。
  • 15批次TSD聚为4类,地黄根质量是影响批次一致性的主要因素。
  • 6个标志物与GAPDH、IL-6、AKT1、CASP3、EGFR等血栓相关靶点强结合。

核心结论

  • 桃红四物汤通过多成分多靶点发挥抗血栓作用,筛选出6个与活血化瘀功效相关的质量标志物。

研究设计与样本

  • 采用UPLC-QqQ-MS/MS定量15批次TSD中31个成分,体外抗凝抗血小板实验评价活性,斑马鱼血栓模型评价药效,结合GRA与BP-ANN分析谱效关系,并通过生物信息学、分子对接及qRT-PCR验证。

主要发现

  • 15批次TSD共定量31个化合物,系统聚类分析将批次分为4组,地黄根质量是影响质量一致性的主要因素。
  • TSD在体外具有抗凝和抗血小板聚集活性,在斑马鱼模型中血栓抑制率令人满意。
  • 通过GRA与BP-ANN联用识别19个关键成分,经分子对接和实验验证筛选出6个化合物:地黄苷D、苦杏仁苷、芍药苷、阿魏酸、羟基红花黄色素A和绿原酸。
  • 6个成分与GAPDH、IL-6、AKT1、CASP3、EGFR等血栓相关靶点具有强结合亲和力。

关键数值与推荐

  • 31个成分在15批次TSD中定量,聚类分析分为4组。
  • 识别19个关键成分,最终确认6个Q-Markers。
  • 斑马鱼模型中TSD血栓抑制率满意(原文未给出具体数值)。

临床怎么用

  • 可将6个Q-Markers用于桃红四物汤的质量标准提升与临床合理应用。
  • 地黄根质量应作为TSD批次一致性控制的关键因素。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Taohong Siwu Decoction (TSD), originating from the Qing Dynasty medical text Gynecology Ice Mirror, is a representative formula for treating blood stasis syndrome, with the effects of promoting blood circulation, nourishing blood, and resolving stasis. Following this lead, modern research has revealed that the formula exerts antithrombotic effects through multiple pathways, thereby providing a critical pharmacological basis for its function of "promoting blood circulation and removing blood stasis". However, the pharmacodynamic material basis underlying this efficacy awaits further clarification. AIM OF THE STUDY: This study aims to establish a multidimensional spectrum-effect correlation model for TSD by integrating its chemical composition with relevant biological activity and antithrombotic efficacy. The goal is to identify quality markers (Q-Markers) that are closely associated with its effects of promoting blood circulation and resolving blood stasis. MATERIALS AND METHODS: UPLC-QqQ-MS/MS was used to quantify 31 components in TSD. Its biological activity was assessed via in vitro anticoagulant and antiplatelet assays, and efficacy via a zebrafish thrombosis model. The study employed grey relational analysis (GRA) and backpropagation neural networks (BP-ANN) to analyze component-activity, activity-efficacy, and component-efficacy correlations. It also constructed a TSD antithrombotic component-target-pathway network via bioinformatics and molecular docking, identifying potential active components. Validation via zebrafish models and quantitative real-time polymerase chain reaction (qRT-PCR) confirmed TSD's multi-component and multi-target interactions, ultimately determining its antithrombotic Q-Markers. RESULTS: Thirty-one compounds across 15 TSD batches were quantified. Systematic cluster analysis categorized the batches into four groups, with Rehmannia glutinosa (Gaertn.) Libosch. ex DC. root quality identified as the main factor affecting TSD's quality consistency. The study confirmed TSD's in vitro anticoagulant and antiplatelet aggregation activity, as well as its satisfactory thrombus inhibition rate in zebrafish models. By combining GRA and BP-ANN, the study identified 19 key components; through molecular docking and experimental validation, six compounds were screened out: rehmannioside D, amygdalin, paeoniflorin, ferulic acid, hydroxysafflor yellow A, and chlorogenic acid. These six components exhibited strong binding affinity to thrombosis-related targets including GAPDH, IL-6, AKT1, CASP3, and EGFR, and were finally confirmed as Q-Markers for TSD's blood circulation-promoting and stasis-resolving efficacy. CONCLUSIONS: Via multidimensional spectrum-effect correlation analysis, this study identified TSD's blood circulation-promoting Q-Markers. These findings lay a foundation for TSD's quality standards/clinical application and provide a reference for traditional Chinese medicine (TCM) constituent-pharmacology research.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Yang R, Wu Y, He L, et al. A multidimensional integrated strategy for identifying anti-thrombotic quality markers(Q-Markers) in Taohong Siwu decoction through combined analysis of chemical profiling, bioactivity, and pharmacodynamic efficacy. J Ethnopharmacol. 2026. PMID: 42217590. doi:10.1016/j.jep.2026.121937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。